ClinicalTrials.Veeva

Menu

Wound Infiltration With Bupivacaine/Adrenalin During Cesarean Section and Postoperative Pain.

H

HaEmek Medical Center, Israel

Status

Completed

Conditions

Cesarean Section

Treatments

Drug: Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT03395912
0151-17-EMC

Details and patient eligibility

About

Thus study evaluates the advantage of infiltration of the surgical wound by local anesthetics in cesarean section on post operative pain relief. In the study group before closing the skin, both sides of the incision (top and bottom) will be infiltrated by 30 ml of 0.25% BUPIVACAINE and ADRENALIN at 1: 200,000 concentration and then closing the skin. In the control group, the skin will be closed without infiltration. Our hypothesis is that subcutaneous infiltration of the surgical wound by BUPIVACAINE + ADRENALIN at the end of cesarean section will reduce the intensity of post operative pain.

Full description

Cesarean section is one of the most common procedures in the world. There is an advantage in preventing pain after cesarean section, as opposed to treating pain that has already started. The infiltration of surgical wounds by local anesthetics is accepted as an effective method for preventing pain after various operations. In this study women who are admitted for a cesarean section will be randomly allocated into 2 groups. In the study group after the closure of the fascia above the rectus muscles, and before closing the skin, both sides of the incision (top and bottom) will be infiltrated by 30 ml of 0.25% BUPIVACAINE and ADRENALIN at 1: 200,000 concentration and then closing the skin. In the control group, the skin will be closed without infiltration.

Enrollment

288 patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cesarean section with regional anesthesia
  • singleton
  • pfannenstiel incision

Exclusion criteria

  • cesarean section with general anesthesia
  • maternal liver or kidney disease
  • allergy to Bupivacaine
  • allergy to Adrenalin
  • intrauterine fetal death
  • major fetal malformations

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

288 participants in 2 patient groups

Intervention
Experimental group
Description:
Infiltration of the subcutaneous layer with local anesthetic and combined with adrenaline.
Treatment:
Drug: Intervention
control
No Intervention group
Description:
Abdominal layers will be closed without Infiltration .

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems